NCT03226522: A trial that was reported late by Axsome Therapeutics, Inc.
This trial has reported, although it was 668 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03226522 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects With Dementia of the Alzheimer's Type |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 13, 2017 |
| Completion date | April 17, 2020 |
| Required reporting date | April 17, 2021, midnight |
| Actual reporting date | Feb. 14, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 668 |